Platinum Based Ovarian Cancer Treatment Market: Current Analysis and Forecast (2022-2028)
$3999 – $6999
Emphasis on Drug Type (Cisplatin, Carboplatin); Dosage Form (Intravenous Powder, Intravenous Solution); End-Users (Hospital, Cancer Research Institutes, Others); and Region/Country
The Platinum based ovarian cancer treatment market is expected to grow at a strong CAGR of around 8% during the forecast period. Platinum-based ovarian cancer treatment refers to the use of chemotherapy drugs that contain platinum to treat ovarian cancer. Platinum drugs, such as cisplatin and carboplatin are effective at killing cancer cells by damaging their DNA and preventing them from dividing. Carboplatin is the most commonly used platinum drug for ovarian cancer treatment. This type of chemotherapy is often given in combination with other chemotherapy drugs or targeted therapy drugs, depending on the stage and type of ovarian cancer. The rising incidences of ovarian cancer globally are the major attributing factor for the growth of the ovarian cancer treatment market including platinum-based treatment. For instance, according to Globocan’s 2020 projections, by 2040, the number of women around the world diagnosed with ovarian cancer will rise almost 42% to 445,721. The number of women dying from ovarian cancer each year is projected to increase to 313,617 an increase of over 50% from 2020. Furthermore, the rising number of clinical researchers on combination drugs with platinum based drugs for treatment also catalyses the growth of the market.
Some of the major players operating in the market include Eli Lilly and Co, Bristol-Myers Squibb Co, Novartis AG, Pfizer Inc., Roche Holding AG Genussscheine, AstraZeneca, Merck KGaA, Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst drug types, the cisplatin segment held the highest CAGR of the market in 2021.”
Based on the drug type, the market has been categorized into cisplatin and carboplatin. Among them, the cisplatin segment is expected to grow at the highest CAGR in the market. In the case of certain forms of ovarian cancer, particularly those that are platinum-sensitive, cisplatin is superior to carboplatin in terms of therapeutic efficacy which is likely to boost the growth of the segment. For instance, according to the Journal of Clinical Oncology in 2020, cisplatin was found to be more effective than carboplatin in treating advanced ovarian cancer in patients who had not previously received platinum-based chemotherapy.
“Amongst end-user, the hospitals segment held the significant share in the market in 2021.”
Based on the end-user, the market has been categorized into hospitals, cancer research institutes and others. Among them, the hospital category is to witness higher adoption of platinum-based ovarian cancer treatment and is expected to grow at a significant share in the market. Hospitals frequently have more infrastructure and resources than cancer institutes, which can enable them to provide comprehensive cancer treatment services, such as platinum-based chemotherapy. In addition, hospitals may have stronger relationships with health insurance providers, making it easier for patients to access their services.
“North America dominated the platinum based ovarian cancer treatment market in 2021.”
North America constitutes a major market for the platinum based ovarian cancer treatment industry. It is characterized by a high level of competition, with several pharmaceutical companies offering platinum-based chemotherapy drugs for the treatment of ovarian cancer. Further, countries such as U.S. and Canada are present in the region, and the presence of well-established healthcare infrastructure in these countries attributes to the dominating share of North America in the global market. The North American region is currently witnessing rising incidences of ovarian cancer which is an important attributing actor for the majority share of the region in the global market. For instance, as per the American Cancer Society, about 19,710 women will receive a new diagnosis of ovarian cancer and about 13,270 women will die from ovarian cancer.
Platinum based ovarian cancer treatment Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
The global Platinum based ovarian cancer treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
You can also purchase parts of this report. Do you want to check out a section wise
|2.1.||Research Process of the Transplantation Market|
|2.2.||Research Methodology of the Transplantation Market|
|5||IMPACT OF COVID-19 ON THE TRANSPLANTATION MARKET|
|6||GLOBAL ONLINE LANGUAGE LEARNING PLATFORM MARKET REVENUE, 2020-2028F|
|10.1||NORTH AMERICA TRANSPLANTATION MARKET|
|10.1.3||Rest of North America|
|10.2||EUROPE TRANSPLANTATION MARKET|
|10.2.6||Rest of Europe|
|10.3||ASIA PACIFIC TRANSPLANTATION MARKET|
|10.3.5||Rest of Asia Pacific|
|10.4||REST OF THE WORLD TRANSPLANTATION MARKET|
|12||TRANSPLANTATION MARKET OPPORTUNITIES|
|13||TRANSPLANTATION MARKET TRENDS & INSIGHTS|
|14.1||Demand Side Analysis|
|14.2||Supply Side Analysis|
|15||VALUE CHAIN ANALYSIS|
|17.1.1||Porter’s Five forces analysis|
|18.7.||F. Hoffmann-La Roche Ltd|
Research Methodology for the Platinum Based Ovarian Cancer Treatment Market Analysis (2022-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Platinum based ovarian cancer treatment market were the three major steps undertaken to create and analyze the adoption of Platinum based ovarian cancer treatment in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Platinum based ovarian cancer treatment market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Platinum based ovarian cancer treatment market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Platinum based ovarian cancer treatment market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as drug type, dosage form, and end-users. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the platinum based ovarian cancer treatment market. Further, we conducted factor analysis using dependent and independent variables such as drug type, dosage form, and end-users of the Platinum based ovarian cancer treatment market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Platinum based ovarian cancer treatment market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Platinum based ovarian cancer treatment market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the Platinum based ovarian cancer treatment market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global Platinum based ovarian cancer treatment market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Platinum based ovarian cancer treatment market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the drug type, dosage form, and end-users in the global Platinum based ovarian cancer treatment market.
The main objective of the Global Platinum based ovarian cancer treatment Market Study
The current & future market trends of the global Platinum based ovarian cancer treatment market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the Platinum based ovarian cancer treatment market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of the drug type, dosage form, and end-users
- Define and analysis of the regulatory framework for the Platinum based ovarian cancer treatment industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the Platinum based ovarian cancer treatment market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the Platinum based ovarian cancer treatment market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry